Immune & Wellness Support
Thymosin Alpha-1
A thymus-derived peptide with a substantial international clinical literature in immune regulation.
- Physician reviewed
- 503A pharmacy compounded
- Patient-specific prescription
Formats & pricing
- 10mg vial — reconstituted injectable$190
Pricing reflects the compounded preparation and physician review. Final therapy and dosing are determined only after your intake is reviewed.
Overview
What is Thymosin Alpha-1?
Thymosin alpha-1 is a 28-amino-acid peptide produced by the thymus gland. It is approved as a medicine in a number of countries for immune indications and has one of the larger evidence bases among peptides in this category.
Mechanism
How it works
Research describes maturation and activation of T-cells and modulation of dendritic cell signaling — an immune-regulating rather than broadly immune-stimulating profile.
Wellness support
Potential wellness support areas
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
- Explored for immune system regulation
- Discussed during periods of immune strain
- Potential support for vaccine and seasonal resilience
- Considered in chronic immune-related protocols
Administration
Format & dosing
Subcutaneous injection, commonly two or more times weekly. Your physician sets the schedule based on your intake.
Labs & monitoring
Labs, testing & monitoring
Your physician determines the final testing requirements for Thymosin Alpha-1 after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status
Recent Labs Recommended
Commonly reviewed at baseline
- CBC with differential
- Comprehensive metabolic panel (CMP)
- hs-CRP
- Immunoglobulins where clinically relevant
Follow-up & monitoring
CBC with differential is often repeated at 8 to 12 weeks alongside a review of immune symptom burden.
Who may not be a candidate
- Pregnancy or nursing
- Active malignancy without oncology clearance
- Known hypersensitivity to the preparation
- Immunosuppressive therapy or transplant without specialist clearance
Medication interactions
Your physician reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Safety
Safety & considerations
Compounded preparations are not FDA-approved in the US. Patients with autoimmune conditions or on immunosuppressive therapy require careful physician review.
Regulatory status: Compounded. Evidence level: Moderate. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed physician after review of your history.
Related therapies
Physician reviewed
Every protocol is approved by a licensed physician.
503A compounded
Prepared by licensed US compounding pharmacies.
Patient-specific Rx
Prescriptions are issued in your name only.
No membership
No concierge fee and no subscription to browse or begin.